RAPT Therapeutics Management

Management criteria checks 2/4

RAPT Therapeutics' CEO is Brian Wong, appointed in Aug 2015, has a tenure of 8.92 years. total yearly compensation is $6.59M, comprised of 9.2% salary and 90.8% bonuses, including company stock and options. directly owns 1.41% of the company’s shares, worth €1.27M. The average tenure of the management team and the board of directors is 4.5 years and 7.2 years respectively.

Key information

Brian Wong

Chief executive officer

US$6.6m

Total compensation

CEO salary percentage9.2%
CEO tenure8.9yrs
CEO ownership1.4%
Management average tenure4.5yrs
Board average tenure7.2yrs

Recent management updates

Recent updates

CEO Compensation Analysis

How has Brian Wong's remuneration changed compared to RAPT Therapeutics's earnings?
DateTotal CompensationSalaryCompany Earnings
Mar 31 2024n/an/a

-US$118m

Dec 31 2023US$7mUS$605k

-US$117m

Sep 30 2023n/an/a

-US$109m

Jun 30 2023n/an/a

-US$99m

Mar 31 2023n/an/a

-US$93m

Dec 31 2022US$5mUS$580k

-US$84m

Sep 30 2022n/an/a

-US$79m

Jun 30 2022n/an/a

-US$76m

Mar 31 2022n/an/a

-US$73m

Dec 31 2021US$3mUS$540k

-US$69m

Sep 30 2021n/an/a

-US$64m

Jun 30 2021n/an/a

-US$60m

Mar 31 2021n/an/a

-US$56m

Dec 31 2020US$4mUS$500k

-US$53m

Sep 30 2020n/an/a

-US$53m

Jun 30 2020n/an/a

-US$49m

Mar 31 2020n/an/a

-US$47m

Dec 31 2019US$2mUS$447k

-US$43m

Sep 30 2019n/an/a

-US$39m

Jun 30 2019n/an/a

-US$40m

Mar 31 2019n/an/a

-US$37m

Dec 31 2018US$1mUS$425k

-US$36m

Compensation vs Market: Brian's total compensation ($USD6.59M) is above average for companies of similar size in the German market ($USD516.04K).

Compensation vs Earnings: Brian's compensation has increased whilst the company is unprofitable.


CEO

Brian Wong (52 yo)

8.9yrs

Tenure

US$6,591,617

Compensation

Dr. Brian Russell Wong, M.D., Ph.D. serves as Venture Partner at The Column Group, LLC since joining the firm in 2022. He has been Chief Executive Officer and Director at RAPT Therapeutics, Inc. since Augu...


Leadership Team

NamePositionTenureCompensationOwnership
Brian Wong
CEO, President & Director8.9yrsUS$6.59m1.41%
$ 1.3m
Rodney K. Young
CFO, Principal Accounting Officer & Secretary4.6yrsUS$2.18m0.034%
$ 30.3k
William Ho
Chief Medical Officer9.2yrsUS$1.90m0.045%
$ 40.7k
Steve Young
Vice President of Technologyno datano datano data
Dirk Brockstedt
Chief Scientific Officer5.1yrsUS$1.48m0.074%
$ 66.7k
Michael Listgarten
General Counsel1.5yrsno datano data
Gwen Carscadden
Chief Human Resources Officer2.2yrsno datano data
Paul Kassner
Senior Vice President of Quantitative & Computational Biology4.3yrsno datano data
David Wustrow
Senior Vice President of Drug Discovery & Preclinical Development5.5yrsno datano data
Jennifer Nicholson
Senior Vice President of Regulatory Affairs & Quality Assurance1.8yrsno datano data
Nipun Davar
Senior Vice President of Technical Operationsless than a yearno datano data

4.5yrs

Average Tenure

57.5yo

Average Age

Experienced Management: 0RA's management team is considered experienced (4.5 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Brian Wong
CEO, President & Director8.9yrsUS$6.59m1.41%
$ 1.3m
William Rieflin
Independent Chairman of the Board9.2yrsUS$300.28k0.27%
$ 244.7k
Mary Gray
Independent Director4.6yrsUS$277.78k0%
$ 0
Drew Pardoll
Member of Scientific Advisory Board7.2yrsno datano data
Philip Greenberg
Member of Scientific Advisory Board7.2yrsno datano data
Alexander Rudensky
Chairman of Scientific Advisory Boardno datano datano data
Antoni Ribas
Member of Scientific Advisory Boardno datano datano data
Scott Antonia
Member of Scientific Advisory Board6.8yrsno datano data
Emma Guttman-Yassky
Member of Scientific Advisory Board5yrsno datano data
Michael Giordano
Independent Director6.5yrsUS$267.78k0%
$ 0
Linda Kozick
Independent Director7.6yrsUS$260.78k0%
$ 0
Robert Zamboni
Member of Scientific Advisory Boardno datano datano data

7.2yrs

Average Tenure

65yo

Average Age

Experienced Board: 0RA's board of directors are considered experienced (7.2 years average tenure).


Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.